Formulation of peptide toxin

A peptide formulation comprising: a) a peptide that is selected from any of the following sequences: SEQ ID NO: 117, SEQ ID NO: 118, or SEQ ID NO: 119; b) a polar organic solvent selected from acetone, methanol, ethanol, propanol and all its isomers, methyl ethyl ketone, diethyl ketone, acetonitrile and ethyl acetoacetate; c) a polar aprotic solvent selected from: dimethylsulfoxide (DMSO), dimethylformamide, dioxane and hexamethylphosphorotriamide; d) wherein said polar organic solvent comprises 70 to 99 percent (%) of the final volume of the formulation; e) wherein said polar aprotic solvent or adjuvant comprises from about 30 to about 1 percent (%) of the final volume of the suspension; f) an optional aqueous phase, wherein said aqueous phase comprises from 0 (zero) to about 10 percent (%) of the final volume of the suspension.